DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 02 · Volume 50 · März 2017 DOI: 10.1055/s-007-33576

Review

49
Colle, R.; de Larminat, D.; Rotenberg, S.; Hozer, F.; Hardy, P.; Verstuyft, C.; Fève, B.; Corruble, E.: PPAR-γ Agonists for the Treatment of Major Depression: A Review

Original Paper

56
Novick, Diego; Montgomery, William; Treuer, Tamas; Moneta, Maria Victoria; Haro, Josep Maria: Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative Symptoms

Original Paper

64
Kashani, L.; Eslatmanesh, S.; Saedi, N.; Niroomand, N.; Ebrahimi, M.; Hosseinian, M.; Foroughifar, T.; Salimi, S.; Akhondzadeh, S.: Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial

Original Paper

69
Takeuchi, T.; Takenoshita, S.; Taka, F.; Nakao, M.; Nomura, K.: The Relationship between Psychotropic Drug Use and Suicidal Behavior in Japan: Japanese Adverse Drug Event Report
74
Fujioi, J.; Iwamoto, K.; Banno, M.; Kikuchi, T.; Aleksic, B.; Ozaki, N.: Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study